Department of Obstetrics and Gynecology, Faculty of Medicine, Oita University, Idaigaoka 1-1, Hasama-machi, Yufu-shi, Oita, 879-5593, Japan.
Division of Obstetrics and Gynecology, Support System for Community Medicine, Faculty of Medicine, Oita University, Oita, Japan.
Reprod Biol Endocrinol. 2020 Apr 16;18(1):31. doi: 10.1186/s12958-020-00590-3.
A number of microRNAs are aberrantly expressed in endometriosis and are involved in its pathogenesis. Our previous study demonstrated that has-miR-100-5p expression is enhanced in human endometriotic cyst stromal cells (ECSCs). The present study aimed to elucidate the roles of has-miR-100-5p in the pathogenesis of endometriosis.
Normal endometrial stromal cells (NESCs) were isolated from normal eutopic endometrium without endometriosis. Using hsa-miR-100-5p-transfected NESCs, we evaluated the effect of hsa-miR-100-5p on the invasiveness of these cells by Transwell invasion assay and in-vitro wound repair assay. We also investigated the downstream signal pathways of hsa-miR-100-5p by microarray analysis and Ingenuity pathways analysis.
hsa-miR-100-5p transfection enhanced the invasion and motility of NESCs. After hsa-miR-100-5p transfection, mRNA expression of SWItch/sucrose non-fermentable-related matrix-associated actin-dependent regulator of chromatin subfamily D member 1 (SMARCD1) was significantly attenuated. Whereas, the expression of matrix metallopeptidase 1 (MMP1) mRNA and active MMP1 protein levels was upregulated.
We found that SMARCD1/MMP-1 is a downstream pathway of hsa-miR-100-5p. hsa-miR-100-5p transfection enhanced the motility of NESCs by inhibiting SMARCD1 expression and MMP1 activation. These findings suggest that enhanced hsa-miR-100-5p expression in endometriosis is involved in promoting the acquisition of endometriosis-specific characteristics during endometriosis development. Our present findings on the roles of hsa-miR-100-5p may thus contribute to understand the epigenetic mechanisms involved in the pathogenesis of endometriosis.
许多 microRNAs 在子宫内膜异位症中表达异常,参与其发病机制。我们之前的研究表明,人源 miR-100-5p 在人子宫内膜异位症囊肿基质细胞(ECSCs)中的表达增强。本研究旨在阐明 miR-100-5p 在子宫内膜异位症发病机制中的作用。
从没有子宫内膜异位症的正常在位子宫内膜中分离正常子宫内膜基质细胞(NESCs)。使用 hsa-miR-100-5p 转染 NESCs,通过 Transwell 侵袭实验和体外划痕修复实验评估 hsa-miR-100-5p 对这些细胞侵袭能力的影响。我们还通过微阵列分析和 Ingenuity 通路分析研究了 hsa-miR-100-5p 的下游信号通路。
hsa-miR-100-5p 转染增强了 NESCs 的侵袭和迁移能力。hsa-miR-100-5p 转染后,SWItch/sucrose non-fermentable-related matrix-associated actin-dependent regulator of chromatin subfamily D member 1(SMARCD1)的 mRNA 表达明显减弱。而基质金属蛋白酶 1(MMP1)mRNA 和活性 MMP1 蛋白水平的表达上调。
我们发现 SMARCD1/MMP-1 是 hsa-miR-100-5p 的下游通路。hsa-miR-100-5p 转染通过抑制 SMARCD1 表达和 MMP1 激活增强 NESCs 的迁移能力。这些发现表明,子宫内膜异位症中 hsa-miR-100-5p 的表达增强参与了子宫内膜异位症发展过程中获得子宫内膜异位症特异性特征的过程。我们目前关于 hsa-miR-100-5p 作用的研究结果可能有助于理解子宫内膜异位症发病机制中的表观遗传机制。